Andreas Sonnen

Dr. Andreas Sonnen

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
RFRachel Flach
Rachel Flach
NFNina L. Fransen
Nina L. Fransen
ASAndreas Sonnen
Andreas Sonnen
TNTri Nguyen
Tri Nguyen
GBGerben Eise Breimer
Gerben Eise Breimer
PDPaul J van Diest
Paul J van Diest
Building on a growing number of pathology labs having a full digital infrastructure for pathology diagnostics, there is a growing interest in implementing artificial intelligence (AI) algorithms for diagnostic purposes. This article provides an overview of the current status of the digital pathology infrastructure at the University Medical Center Utrecht and our roadmap for implementing AI algorithms in the next few years.

11 April 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
CRCharis Rousou
Charis Rousou
NKNicky van Kronenburg
Nicky van Kronenburg
ASAndreas Sonnen
Andreas Sonnen
MDMarijke van Dijk
Marijke van Dijk
CMChrit Moonen
Chrit Moonen
RDRoel Deckers
Roel Deckers
Drug delivery to the retina is one of the major challenges in ophthalmology due to the biological barriers that protect it from harmful substances in the body. Despite the advancement in ocular therapeutics, there are many unmet needs for the treatment of retinal diseases. Ultrasound combined with microbubbles (USMB) was proposed as a minimally invasive method for improving delivery of drugs in the retina from the blood circulation. This study aimed to investigate the applicability of USMB for the delivery of model drugs (molecular weight varying from 600 Da to 20 kDa) in the retina of ex vivo porcine eyes. A clinical ultrasound system, in combination with microbubbles approved for clinical ultrasound imaging, was used for the treatment. Intracellular accumulation of model drugs was observed in the cells lining blood vessels in the retina and choroid of eyes treated with USMB but not in eyes that received ultrasound only. Specifically, 25.6 ± 2.9% of cells had intracellular uptake at mechanical index (MI) 0.2 and 34.5 ± 6.0% at MI 0.4. Histological examination of retinal and choroid tissues revealed that at these USMB conditions, no irreversible alterations were induced at the USMB conditions used. These results indicate that USMB can be used as a minimally invasive targeted means to induce intracellular accumulation of drugs for the treatment of retinal diseases.


1 July 2025 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
SASabbir Ahmed
Sabbir Ahmed
SCShelley X. L. Chen
Shelley X. L. Chen
JLJacqueline P. F. E. Lucas
Jacqueline P. F. E. Lucas
SKSebastiaan N. Knoppert
Sebastiaan N. Knoppert
RHRachel Harwood
Rachel Harwood
RMRosalinde Masereeuw
Rosalinde Masereeuw
Plasma indoxyl sulfate (IS) and its clearance correlate better with tubular injury markers (Kim-1, NGAL) than filtration markers (GFR, creatinine) in chronic nephrectomy rats and chronic/acute ischemic injury (IRI) in mice. Mass spectrometry imaging showed higher cortical but lower medullary IS accumulation in mice, in which proximal tubular transporters were downregulated. In vitro organic anion transporter 1-mediated IS transport decreased post-IRI. Together, plasma IS and its clearance may be used as kidney tubular function markers.